U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07232420) titled 'A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors' on Nov. 14.
Brief Summary: This study is an open, multicenter, non-randomized phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of BL-M24D1 in patients with locally advanced or metastatic non-small cell lung cancer and other solid tumors.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Non Small Cell Lung Cancer
Solid Tumor
Intervention:
DRUG: BL-M24D1
Administration by intravenous infusion for a cycle of 2 weeks.
Recruit...